DementiaNCT06888713
Telemonitoring of Activities of Daily Living in Home Care Services of Older Adults With Cognitive Deficits
A study testing Telemonitoring of ADL in people with Dementia, run by Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal at 3 sites in Canada.
Trial summary
In Canada, it is estimated that two million people are users of publicly funded home care services, with more than half of them being 65 years and older. Although home care services are considered a priority by Canadian provinces, in Québec alone, more than 46 000 people were waiting for those services in 2022. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Dementia
- What is being tested?
- Telemonitoring of ADL
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 3 sitesCanada
- Study dates
- 1 Apr 2025to 31 Dec 2028
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- 1) be an older adult (> 65 years old), 2) have cognitive deficits as reported in the medical record, 3) live alone, at home, 4) be a care recipient of home care services, 5) speak French or English
Who cannot join
- None
Trial locations and contacts
3 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Canada3 sites, 3 recruiting
- Recruiting
CIUSSS Centre-sud-de-l'île-de-Montréal
Montreal, Quebec
Nathalie Bier, 5149094483, nathalie.bier@umontreal.ca
- Recruiting
CIUSSS de l'Est-de-l'île-de-Montréal
Montreal, Quebec
Nathalie Bier, 5149094483, nathalie.bier@umontreal.ca
- Recruiting
CIUSSS Saguenay-Lac-St-Jean
Montreal, Quebec
Nathalie Bier, 5149094483, nathalie.bier@umontreal.ca
About this study
Official title: Telemonitoring of Activities of Daily Living in Home Care Services of Older Adults With Cognitive Deficits: a Large-scale Action Design Research Study
In Canada, it is estimated that two million people are users of publicly funded home care services, with more than half of them being 65 years and older. Although home care services are considered a priority by Canadian provinces, in Québec alone, more than 46 000 people were waiting for those services in 2022. The provision of home care services is hampered by limited funding and growing demand from among an aging population, among other factors. These challenges have led to urgent calls to better support home care in Canada to ensure optimal use of scarce human and financial resources. One of the key strategies to achieve optimal use of resources may be remote monitoring of activities of daily living (ADLs), a type of telehealth. ADL telemonitoring can remotely recognize ADLs such as preparing meals and moving around the home. Past studies have shown that ADL telemonitoring can help in better understanding older adults' home care needs, thereby allowing for more personalized ADL interventions. Previous projects have also allowed for the developement of NEARS-SAPA, a telemonitoring system for ADLs. In these past projects, it was identified how NEARS-SAPA was used by home care services and its ease of use was tested in real environments. In the present project, the benefits of ADL telemonitoring will be tested and its technological capabilities expanded, hence preparing the system for the next big step, i.e. large-scale adoption by home care services. Ultimately, ADL telemonitoring may help the healthcare system determine which service is more appropriate for which person and at what time, thereby optimizing interventions and resource management.
- Conditions
- Dementia
- Being tested
- Telemonitoring of ADL
- Keywords
- Telemonitoring of ADL, Homecare services, IA
- Medical subject headings
- Dementia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Telemonitoring of ADLOther
Telemonitoring of ADL is based on smart environments sensors (non wearables) and gathers information about activity of daily living routines for a better understanding of homecare services needed.
| Study group | Role | What they receive |
|---|---|---|
| Telemonitoring of ADL group | Experimental | Will receive the technology in their home to document if it influenced the homecare services plan. Receives: Other: Telemonitoring of ADL |
| No telemonitoring of ADL | No intervention | Another group will be followed in therms of homecare services received, but without the technology. The control group will be gathered based on archives data only. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of homecare services received to support activities of daily living (ADL)
Number of homecares ADL services received as identified in clinical databases.
Measured: From enrollment until around 12 months of following.
Nature of homecare services received to support activities of daily living (ADL).
The category of services received related to ADL as indicated in clinical databases.
Measured: From enrollement until around 12 months of following.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Mar 2025
- Study start1 Apr 2025
- Primary completion1 Apr 2028 (estimated)
- Study completion31 Dec 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DementiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Nathalie Bier, Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
- Investigators
- Nathalie Bier, Ph.D., Principal investigator, CRIUGM, Université de MontréalCharles Gouin-Vallerand, Ph.D., Principal investigator, Université de SherbrookeKevin Bouchard, Ph.D., Principal investigator, Université du Québec à Chicoutimi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06888713
- Sponsor's protocol ID
- PJT-195697
- Status last verified
- Oct 2026
- First submitted
- 28 Feb 2025
- Last updated
- 22 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided